# Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment

> **NCT05404321** · — · RECRUITING · sponsor: **Centre Francois Baclesse** · enrollment: 163 (estimated)

## Conditions studied

- Triple Negative Breast Cancer
- Organoid

## Interventions

- **OTHER:** Establishment of ex vivo breast cancer organoid models

## Key facts

- **NCT ID:** NCT05404321
- **Lead sponsor:** Centre Francois Baclesse
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-09
- **Primary completion:** 2028-06
- **Final completion:** 2028-12
- **Target enrollment:** 163 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05404321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05404321, "Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05404321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*